Literature DB >> 9095215

The nevoid basal cell carcinoma syndrome: genetics and mechanism of carcinogenesis.

A E Bale1.   

Abstract

The nevoid basal cell carcinoma syndrome is an autosomal dominant disorder that predisposes to basal cell carcinomas of the skin, ovarian fibroma, and medulloblastoma. Unlike many other hereditary disorders associated with cancer, if features widespread birth defects. Laboratory studies of radiation sensitivity and chromosome instability over the past 20 years have generally yielded negative or inconclusive results. Screening for allelic loss in sporadic and hereditary basal cell carcinomas, hereditary ovarian fibromas, and sporadic medulloblastomas provided evidence for a tumor suppressor gene on chromosome 9q important in all three tumor types. Demonstration of a constitutional chromosome 9q deletion in an unusual patient with this syndrome and genetic linkage studies in large kindreds indicated that the nevoid basal cell carcinoma syndrome gene maps to the same location lost in tumors. These data indicate that tumors arise with homozygous inactivation of the gene and imply that it normally functions as a tumor suppressor. In contrast, hemizygous germline mutations lead to multiple congenital anomalies.

Entities:  

Mesh:

Year:  1997        PMID: 9095215     DOI: 10.3109/07357909709115772

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  7 in total

1.  Infected palmer and plantar pits: a rare presentation of Gorlin's syndrome.

Authors:  Thisara Weerasuriya; Raja Swaminathan
Journal:  BMJ Case Rep       Date:  2011-08-31

2.  Identification of genetic loci for basal cell nevus syndrome and inflammatory bowel disease in a single large pedigree.

Authors:  Carolien I Panhuysen; Amir Karban; Alisa Knodle Manning; Theodore M Bayless; Richard H Duerr; Joan E Bailey-Wilson; Ervin H Epstein; Steven R Brant
Journal:  Hum Genet       Date:  2006-05-30       Impact factor: 4.132

Review 3.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 4.  [Basal cell carcinoma and rare form variants].

Authors:  J Liersch; J Schaller
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

5.  FOXG1 dysregulation is a frequent event in medulloblastoma.

Authors:  Adekunle M Adesina; Yummy Nguyen; Vidya Mehta; Hidehiro Takei; Patrick Stangeby; Sonya Crabtree; Murali Chintagumpala; Mary K Gumerlock
Journal:  J Neurooncol       Date:  2007-05-24       Impact factor: 4.130

6.  Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome.

Authors:  Lorenza Pastorino; Annamaria Pollio; Giovanni Pellacani; Carmelo Guarneri; Paola Ghiorzo; Caterina Longo; William Bruno; Francesca Giusti; Sara Bassoli; Giovanna Bianchi-Scarrà; Cristel Ruini; Stefania Seidenari; Aldo Tomasi; Giovanni Ponti
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

Review 7.  Genetic alterations in syndromes with oral manifestations.

Authors:  Krishnamurthy Anuthama; Harikrishnan Prasad; Pratibha Ramani; Priya Premkumar; Anuja Natesan; Herald J Sherlin
Journal:  Dent Res J (Isfahan)       Date:  2013-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.